Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Ocul Pharmacol Ther ; 23(5): 476-80, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17900228

RESUMO

PURPOSE: The aim of this study was to evaluate the duration of the effect of one single dose of brimonidine tartrate 0.15% on pupil diameter, under scotopic conditions, when applied topically in 1 eye of normal subjects. METHODS: The eyes of 19 normal volunteers were randomized so that 1 eye had 1 drop of brimonidine tartrate 0.15% and the other received no medication. Pupil diameter was measured using an infrared pupillometer. The first measure was obtained before the instillation of brimonidine. After that, four measures, with 2-h intervals, were performed. RESULTS: From 19 participants, 14 were women and 5 were men, with a mean age of 25.05 years (standard deviation, +/- 6.98). Before brimonidine instillation, mean pupil diameter in the control eyes was 5.11 mm, and in the brimonidine eyes it was 5.15 mm. After 8 h, the mean pupil size was 4.01 mm in the treated eyes, and 4.56 mm in the untreated eyes. There was a tendency of miotic effect to be more important on the treated eye, as compared to the control eye in all intervals, but this did not reach statistical significance (P = 0.375). When comparing both eyes, independently of the periods, the treated eye had a smaller diameter than the untreated eye (P = 0.038). The miotic effect was observed for at least 8 h after instillation. CONCLUSIONS: Miotic response of brimonidine tartrate 0.15% lasted for at least 8 h and has a significant effect on the nontreated eye.


Assuntos
Agonistas de Receptores Adrenérgicos alfa 2 , Anti-Hipertensivos/farmacologia , Mióticos/farmacologia , Pupila/efeitos dos fármacos , Quinoxalinas/farmacologia , Administração Tópica , Adulto , Anti-Hipertensivos/administração & dosagem , Tartarato de Brimonidina , Adaptação à Escuridão , Técnicas de Diagnóstico Oftalmológico , Feminino , Humanos , Pressão Intraocular/efeitos dos fármacos , Masculino , Mióticos/administração & dosagem , Soluções Oftálmicas , Quinoxalinas/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA